Skip to main content

Table 2 Environmental exposures documented in selected juvenile idiopathic inflammatory myopathy phenotypes

From: Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes

 

Clinical Subgroup

Myositis-Specific Autoantibody Subgroup

Environmental Exposure

JDM

N (%) or Median [IQR]

n = 87

JCTM  

N (%) or Median [IQR]

n = 14

JPM

N (%) or Median [IQR]

n = 5

P Value

OR (95% CI)

Anti-TIF-1

N (%) or Median [IQR]

n = 33

Anti-NXP2

N (%) or Median [IQR]

n = 30

Anti-MDA5

N (%) or Median [IQR]

n = 17

MSA Negative

N (%) or Median [IQR]

n = 14

P Value

OR (95% CI)

Exposures within 1 Year of Diagnosis

Infections

 Any Infection

49 (56.3)

5 (35.7)

4 (80.0)

0.294

 

19 (57.6)

18 (60.0)

6 (35.3)

9 (64.3)

0.135

 

 Gastroenteritis

9 (10.3)

1 (7.1)

1 (20.0)

0.468

 

4 (12.1)

3 (10.0)

0 (0.0)d

4 (28.6)d

0.032d

NCd

 Strep Throat

20 (23.2)

2 (14.3)

1 (20.0)

0.729

 

4 (12.1)

9 (31.0)

3 (17.6)

5 (35.7)

0.102

 

 URI

13 (14.9)

1 (7.1)

0 (0.0)

0.685

 

5 (15.2)

5 (16.7)

2 (11.8)

1 (7.1)

0.647

 

 Influenza

7 (8.0)

0 (0.0)

0 (0.0)

0.589

 

4 (12.1)

1 (3.3)

1 (5.9)

1 (7.1)

0.357

 

UV Exposure

 Any Sunburn

43 (50.0)

8 (57.1)

3 (60.0)

0.775

 

16 (48.5)

14 (46.7)

6 (37.5)

8 (57.1)

0.549

 

 Median Number of Sunburns

0.5 [0.0–2.0]

1.0 [0.0–1.5]

1.0 [0.0–1.0]

0.823

 

0.0 [0.0–20.0]

0.0 [0.0–2.0]

0.0 [0.0–1.0]

1.0 [0.0–1.3]

0.786

 

Heavy Exercises

 Any Heavy Exercise

29 (33.3)

6 (42.9)

2 (40.0)

0.550

 

9 (27.3)

8 (26.7)

8 (47.0)

8 (57.1)

0.091

 

 Exercise Resulting in Muscle Pain

18 (20.7)

4 (28.6)

1 (20.0)

0.498

 

3 (9.0)e

6 (20.0)

5 (29.4)

6 (42.9)e

0.013e

7.5e (1.6–30.5)

 Prolonged Running

15 (17.2)

2 (14.3)

0 (0.0)

0.579

 

3 (9.0)f

4 (13.3)

6 (35.3)f

2 (14.3)

0.047f

5.5f (1.3–21.8)

 Heavy Sports Activity

24 (27.6)

6 (42.9)

1 (20.0)

0.344

 

8 (24.2)

6 (20.0)

8 (47.0)

7 (50.0)

0.074

 

Medications

 Any Medication

59 (67.8)

10 (71.4)

5 (100)

0.316

 

21 (63.6)

21 (70.0)

10 (58.8)d

13 (92.9)d

0.045d

9.1d (1.1–109.0)

 Antibiotics

42 (48.5)

5 (37.5)

3 (60.0)

0.561

 

15 (46.9)

16 (53.3)

5 (29.4)

8 (57.1)

0.138

 

 NSAIDs

24 (28.2)

7 (50.0)

1 (25.0)

0.125

 

9 (29.0)

10 (33.3)

4 (23.5)

5 (35.7)

0.529

 

 Seizure Medication

0 (0.0)

0 (0.0)

1 (20.0)

0.054

 

0 (0.0)

0 (0.0)

0 (0.0)

1 (7.1)

0.298

 

Immunizations

 Any Immunization

50 (57.5)a

10 (71.4)b

0 (0.0)a,b

0.017a

NCa

21 (63.6)

17 (56.7)

9 (52.9)

8 (57.1)

0.549

 

0.011b

NCb

 Influenza

37 (42.5)

7 (50.0)

0 (0.0)

0.080

 

15 (45.5)

14 (46.7)

5 (29.4)

6 (42.9)

0.356

 

 Hepatitis B

0 (0.0)c

2 (15.4)c

0 (0.0)

0.016c

NCc

2 (6.3)

0 (0.0)

0 (0.0)

0 (0.0)

0.492

 

Weight at Diagnosis

 Overweight/Obese

23 (26.7)

1 (7.1)

1 (20.0)

0.117

 

10 (31.3)

7 (23.3)

2 (11.8)

3 (21.4)

0.174

 

 Underweight

6 (7.0)c

6 (42.9)c

0 (0.0)

0.002c

10.0c (2.8–34.0)

3 (9.4)

4 (13.3)

1 (5.9)

3 (21.4)

0.304

 

Major Psychosocial Stressors

 Overall Major Psychosocial Stress Score

0.0 [0.0–0.0]

0.0 [−0.3–0.0]

0.0 [0.0–0.0]

0.572

 

0.0 [0.0–0.0]

0.0 [0.0–0.0]

0.0 [0.0–0.0]

0.0 [0.0–0.0]

0.821

 

 Death or Illness of Significant Person

6 (6.9)

1 (7.1)

0 (0.0)

0.999

 

0 (0.0)

3 (10.0)

2 (11.8)

2 (14.3)

0.084

 

Exposures Beyond 1 Year of Diagnosis

Major Psychosocial Stressors (within 5 Years of Diagnosis)

 Overall Major Psychosocial Stress Score

0.0 [−1.0–0.0]

0.0 [−2.0–0.0]

0.0 [−1.0–0.0]

0.368

 

0.0 [−1.0–0.0]

0.0 [−2.0–0.0]

0.0 [−0.5–1.0]

0.0 [−1.3–0.0]

0.415

 

 Death or Illness of Significant Person

17 (19.5)

4 (28.6)

1 (20.0)

0.482

 

4 (12.1)e

9 (30.0)

2 (11.8)

6 (42.9)e

0.045e

5.4e (1.3–19.6)

Smoke Exposure

 Maternal Smoking during Pregnancy

3 (5.2)

0 (0.0)

0 (0.0)

0.999

 

1 (4.3)

0 (0.0)

2 (18.2)

0 (0.0)

0.118

 

 Parental Smoking during Pregnancy

7 (13.2)

0 (0.0)

1 (50.0)

0.222

 

2 (10.0)

1 (5.3)

2 (18.2)

1 (16.7)

0.430

 

 Secondhand Smoke Exposure

7 (8.0)

3 (21.4)

2 (40.0)

0.073

 

3 (9.1)

2 (6.7)

2 (11.8)

2 (14.3)

0.581

 

Pregnancy Complications

 C Section Birth

23 (36.5)

2 (28.6)

0 (0.0)

0.546

 

9 (37.5)

8 (40.0)

4 (33.3)

3 (33.3)

0.999

 

 Birth < 37 weeks

12 (19.3)

3 (42.9)

0 (0.0)

0.169

 

3 (12.5)

6 (31.6)

4 (33.3)

2 (22.2)

0.153

 

 Preeclampsia or Gestational Hypertension

4 (6.3)

0 (0.0)

0 (0.0)

0.999

 

0 (0.0)

3 (15.0)

1 (8.3)

1 (11.1)

0.086

 

Breastfed

 Breastfed for any period

48 (78.7)

7 (100.0)

3 (100.0)

0.331

 

17 (70.8)

19 (95.0)g

7 (58.3)g

8 (88.9)

0.020g

13.6g (1.7–166.1)

 Breastfed for more than 6 months

25 (52.1)

5 (71.4)

1 (33.3)

0.443

 

7 (41.2)e

11 (57.9)

2 (28.6)d

8 (88.9)d,e

0.035d

20.0d (1.5–256.5)

0.036e

11.4e (1.2–137.2)

Soy Formula

13 (21.0)

0 (0.0)

1 (33.3)

0.333

 

6 (26.1)

3 (15.0)

3 (27.3)

0 (0.0)

0.150

 
  1. Abbreviations: JDM juvenile dermatomyositis, JPM juvenile polymyositis, JCTM juvenile connective tissue myositis, NSAIDs non-steroidal anti-inflammatory drugs, URI upper respiratory Infection, OR odds ratio, CI confidence interval, C section caesarean section, MSA myositis-specific autoantibody
  2. Note that percentages may not reflect the number divided by the total number of subjects when data are missing
  3. Each individual comparison was computed, and the smallest p value is reported, except when more than one comparison is significant
  4. ORs are reported for only significant results (p < 0.050) and are footnoted to delineate the specific comparison
  5. Any infection, heavy exercise, medication, or vaccine refers to any exposure in the category, including those specifically listed in the table
  6. a-gDenote the groups compared and the associated p value and OR